MassMutual Private Wealth & Trust’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $185K | Sell |
4,340
-749
| -15% | -$40.7K | ﹤0.01% | 464 |
|
|
2026
Q1 | $319K | Sell |
5,089
-1,586
| -24% | -$127K | 0.01% | 368 |
|
|
2025
Q4 | $636K | Buy |
6,675
+583
| +10% | +$57.2K | 0.02% | 284 |
|
|
2025
Q3 | $595K | Sell |
6,092
-41
| -0.7% | -$4.25K | 0.02% | 296 |
|
|
2025
Q2 | $659K | Sell |
6,133
-192
| -3% | -$19.4K | 0.02% | 294 |
|
|
2025
Q1 | $638K | Buy |
6,325
+940
| +17% | +$94.7K | 0.02% | 297 |
|
|
2024
Q4 | $481K | Buy |
5,385
+724
| +16% | +$63.7K | 0.01% | 324 |
|
|
2024
Q3 | $391K | Sell |
4,661
-29
| -0.6% | -$2.29K | 0.01% | 330 |
|
|
2024
Q2 | $361K | Buy |
4,690
+705
| +18% | +$51.6K | 0.01% | 341 |
|
|
2024
Q1 | $273K | Buy |
3,985
+576
| +17% | +$37K | 0.01% | 349 |
|
|
2023
Q4 | $197K | Buy |
3,409
+892
| +35% | +$47.6K | 0.01% | 379 |
|
|
2023
Q3 | $133K | Sell |
2,517
-216
| -8% | -$11.3K | ﹤0.01% | 418 |
|
|
2023
Q2 | $148K | Buy |
2,733
+839
| +44% | +$43.8K | 0.01% | 387 |
|
|
2023
Q1 | $94.8K | Buy |
1,894
+798
| +73% | +$37.6K | ﹤0.01% | 428 |
|
|
2022
Q4 | $51K | Buy |
1,096
+96
| +10% | +$4.16K | ﹤0.01% | 478 |
|
|
2022
Q3 | $39K | Buy |
1,000
+406
| +68% | +$16.3K | ﹤0.01% | 492 |
|
|
2022
Q2 | $22K | Sell |
594
-30
| -5% | -$1.22K | ﹤0.01% | 554 |
|
|
2022
Q1 | $28K | Sell |
624
-429
| -41% | -$18.6K | ﹤0.01% | 537 |
|
|
2021
Q4 | $45K | Buy |
1,053
+535
| +103% | +$22.5K | ﹤0.01% | 490 |
|
|
2021
Q3 | $22K | Hold |
518
| – | – | ﹤0.01% | 578 |
|
|
2021
Q2 | $22K | Sell |
518
-86
| -14% | -$3.62K | ﹤0.01% | 562 |
|
|
2021
Q1 | $23K | Buy |
604
+119
| +25% | +$4.5K | ﹤0.01% | 506 |
|
|
2020
Q4 | $17K | Buy |
+485
| New | +$17.5K | ﹤0.01% | 541 |
|
|
2020
Q3 | – | Sell |
-52
| Closed | -$2K | – | 732 |
|
|
2020
Q2 | $2K | Buy |
+52
| New | +$1.87K | ﹤0.01% | 650 |
|
|
2019
Q4 | – | Sell |
-784
| Closed | -$32K | – | 789 |
|
|
2019
Q3 | $32K | Buy |
+784
| New | +$33.2K | ﹤0.01% | 469 |
|
|
2019
Q1 | – | Sell |
-163
| Closed | -$5.76K | – | 873 |
|
|
2018
Q4 | $5.76K | Buy |
163
+30
| +23% | +$1.09K | ﹤0.01% | 641 |
|
|
2018
Q3 | $5.12K | Hold |
133
| – | – | ﹤0.01% | 716 |
|
|
2018
Q2 | $4.35K | Buy |
+133
| New | +$4.01K | ﹤0.01% | 747 |
|
|
2017
Q2 | – | Sell |
-70
| Closed | -$1.74K | – | 1049 |
|
|
2017
Q1 | $1.74K | Buy |
+70
| New | +$1.7K | ﹤0.01% | 888 |
|
Other funds holding BSX
MassMutual Private Wealth & Trust's BSX Position: Q2 2026 in Review
MassMutual Private Wealth & Trust reduced its Boston Scientific (BSX) stake by 15% in Q2 2026, selling an estimated $40.7K and leaving 4,340 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #464.
MassMutual Private Wealth & Trust first reported a position in BSX in Q1 2017 and has held it in 29 quarters since. The position peaked at $659K in Q2 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- MassMutual Private Wealth & Trust held 4,340 shares of Boston Scientific worth $185K as of Q2 2026.
- MassMutual Private Wealth & Trust sold 749 Boston Scientific shares in Q2 2026, an estimated $40.7K.
- Boston Scientific made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #464 holding.
- MassMutual Private Wealth & Trust first reported a position in Boston Scientific in Q1 2017 and has held it in 29 quarters since.
- MassMutual Private Wealth & Trust's Boston Scientific position peaked at $659K in Q2 2025.
- 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.